<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>A 16-yr-old girl received liver transplantation for <z:hpo ids='HP_0004787'>fulminant hepatitis</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain><z:hpo ids='HP_0001915'>Aplastic anemia</z:hpo> developed, and she received hematopoietic stem cell transplantation (HSCT) </plain></SENT>
<SENT sid="2" pm="."><plain>Eleven months after liver transplantation, abdominal lymph node enlargement and colon <z:mpath ids='MPATH_579'>ulcers</z:mpath> were observed, and colon biopsy showed posttransplant <z:hpo ids='HP_0005523'>lymphoproliferative disorder</z:hpo> (PTLD) </plain></SENT>
<SENT sid="3" pm="."><plain>Immunosuppression reduction was attempted, but it produced no therapeutic effect </plain></SENT>
<SENT sid="4" pm="."><plain>Fourteen months after liver transplantation, she received a second HSCT due to engraftment failure, and PTLD resolved completely </plain></SENT>
<SENT sid="5" pm="."><plain>The second HSCT can serve as cellular therapy for PTLD </plain></SENT>
</text></document>